Connect
Comment receiving replies
Just another point of view from a recent interview (1/25) of Dr. Khera who treats prostate cancer patients and individualizes TRT:
"The second paper [concerns data from a recent study by Flores et al]. This is a large series looking at almost 5200 [patients] who underwent radical prostatectomy [RP] and had groups grade 1 to 3 on RP pathology, of which 198 patients received testosterone therapy. These authors found there was no difference in biochemical recurrence in men receiving testosterone vs those men not receiving testosterone after radical prostatectomy. They also noticed that the men who received testosterone had a much lower risk of biochemical recurrence, although it was not statistically significant."
Research regarding TRT in men with a history of prostate cancer is ongoing.
Replies to "Just another point of view from a recent interview (1/25) of Dr. Khera who treats prostate..."
Connect
That’s a mind blowing study, doc…turns everything on its ear. One point though - did the paper mention the Gleason scores of the 5200 men?
I mean, if they were all 3+3’s and small tumor 3+4’s with low Deciphers, I could really get behind it.
But then there’s you and your aggressive case- now on TRT!!
It seems that the triplet therapy you endured really worked for you in not only beating down the cancer but possibly “curing” (we don’t use that word!) it?
Very happy for you!
Phil